This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mayr, M. Search for Related Content PubMed Articles by Mayr, M. Related Collections Biochemistry and metabolism Animal models of human disease Functional genomics Other diagnostic testing

Advances in Genetics, Proteomics, and Metabolomics

Metabolomics

Ready for the Prime Time?

Manuel Mayr, MD, PhD

From the Cardiovascular Division, King’s College, London School of Medicine, King’s College London, UK.

Correspondence to Manuel Mayr, MD, PhD, Cardiovascular Division, The James Black Centre, King’s College, London, 125 Coldharbour Ln, London SE5 9NU, UK. E-mail manuel.mayr@kcl.ac.uk

Key Words: metabolism • mass spectrometry • spectroscopy • proteonics

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Metabolomics is one of the most rapidly growing areas of contemporary science. Although classic genetics aims to link variations in the DNA sequence directly to distinct phenotypes, "-omic" technologies allow us to shift the focus from the specific gene to the actual effects of the gene itself. Because neither the transcriptional or protein profile can be directly correlated with metabolite concentrations, the importance of measuring small-molecule metabolites has become increasingly clear. In view of the rapid progress in metabolomic techniques, metabolomics is expected to become more widely applied to cardiovascular research. Metabolomics brings the promise of the identification of potential biomarkers and alterations in biochemical pathways, which will facilitate the transition from a reductionistic approach to a more integrated science. Because the relative lack of attention given to the system behavior hampers our progress in translating basic science research into clinical applications, the holistic nature of these emerging techniques may yield valuable new strategies for the prevention and treatment of cardiovascular diseases.

By analogy to the genome, the metabolome is defined as the total complement of small-molecule metabolites found in or produced by an organism. The most recent estimates place the number of endogenous metabolites (metabolites synthesized by enzymes encoded in the human genome) at approximately a few thousand, far less than had been previously predicted.¹ Importantly, the size of the exogenous metabolome (metabolites not synthesized in the body but consumed as food or generated by host-specific microbes) is far greater, and there is often a spatial separation between metabolite . . . [Full Text of this Article]

This article has been cited by other articles:

				H. Ashrafian and S. Neubauer Metabolomic Profiling of Cardiac Substrate Utilization: Fanning the Flames of Systems Biology? Circulation, April 7, 2009; 119(13): 1700 - 1702. [Full Text] [PDF]